Neuraura Biotech Inc | Wearable Biotech Device for PCOS
Neuraura Biotech Inc. is a Calgary-based medtech company developing groundbreaking wearable and implantable bioelectronic devices to transform how chronic conditions are monitored and treated.
Overview
Neuraura is a medtech company based in Calgary, Alberta, specializing in wearable and implantable bioelectronic devices. The company is developing a treatment for polycystic ovary syndrome (PCOS), which affects over 10% of women and is a leading cause of female infertility. Neuraura aims to provide an effective, affordable, over-the-counter device that enhances the body's natural processes rather than merely alleviating symptoms. The initial application focuses on treating pelvic pain, utilizing a predicate regulatory code under the FDA 510(k) pathway. Following market entry, Neuraura plans to expand the device's claims to address insulin resistance and other PCOS-related issues through targeted clinical studies and user data. In the long term, the company intends to create a premium device for the treatment of pre-diabetes and diabetes.
Details
- Category
- Medical Equipment Manufacturing
- Headquarters
- Calgary, Alberta
- Type
- Privately Held
- Founded
- 2017
- Followers
- 2,736
- Specialties
- Neurotechnology, wearables, neuromodulation, women's health, metabolic conditions, reproductive health, and femtech
- Locations
- 450 1 St SW Calgary, Alberta T2P, CA
Funding
Total rounds: 7
Last round: Grant, Apr 27, 2025